Darolutamide plus ADT and Docetaxel Improves Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer.
| Published in: | Oncology Nurse-APN/PA Vol. 15; no. 3; p. 21 |
|---|---|
| Main Author: | |
| Format: | brief item pictorial Journal Article |
| Published: |
Amplity Health
Jun2022
|
| Online Access: | View this record in EBSCOhost |
| Description not available. |